Balchem (BCPC) Stock Rating Lowered by BidaskClub
Balchem (NASDAQ:BCPC) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report released on Friday.
Balchem (BCPC) traded down $0.52 during midday trading on Friday, reaching $81.11. The company’s stock had a trading volume of 77,100 shares, compared to its average volume of 96,274. Balchem has a twelve month low of $71.95 and a twelve month high of $89.50. The company has a quick ratio of 1.49, a current ratio of 2.16 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $2,616.67, a P/E ratio of 40.76 and a beta of 1.09.
Balchem (NASDAQ:BCPC) last released its quarterly earnings results on Tuesday, November 7th. The basic materials company reported $0.63 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.01. The business had revenue of $150.72 million for the quarter. Balchem had a return on equity of 14.68% and a net margin of 11.11%.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/22/balchem-bcpc-stock-rating-lowered-by-bidaskclub-2.html.
Balchem Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.